NCT06782815 Acupoint Selection Based on Meridian Theory in Primary Insomnia of Liver Depression and Spleen Deficiency Type
| NCT ID | NCT06782815 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chuanlong Zhou |
| Condition | Primary Insomnia |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2024-01-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The classical literature combined with modern medicine to select acupoints, in order to intervene in the autonomic nerve function of the superior cervical sympathetic ganglion as an opportunity, put forward the meridian acupoints mainly to reconcile the head orifices Ying Wei, acupuncture treatment of primary insomnia clinical research. Heart rate variability ( HRV ), Pittsburgh sleep quality index ( PSQI ), polysomnography ( PSG ) and the MOS item short from health survey ( SF-36 ) were observed. Insomnia Severity Index ( ISI ), Dysfunctional Beliefs and Attitudes about Sleep Scale 16 ( DBAS-16 ), GABA, Glx and other secondary indicators were used to clarify the clinical short-term and long-term efficacy of different acupoints in the treatment of patients with primary insomnia and the intervention effect on HRV.
Eligibility Criteria
Inclusion Criteria: * In line with the diagnostic criteria of insomnia of liver depression and spleen deficiency type in traditional Chinese medicine : * In line with the Western diagnostic criteria for insomnia ; * 18 ≤ age ≤ 40 years old, male or female ; * patients with a course of more than two weeks ; Note: The above criteria must be met for inclusion in this study. Exclusion Criteria: * Insomnia caused by a variety of organic diseases, neurological or psychiatric disorders * Pregnancy, lactation or drug allergy * There are more serious primary diseases such as cardiovascular and cerebrovascular diseases, gastrointestinal diseases, endocrine system diseases, or psychiatric patients. * Patients with coagulation dysfunction and bleeding tendency.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06782815 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Primary Insomnia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06782815 currently recruiting?
Yes, NCT06782815 is actively recruiting participants. Contact the research team at 471388079@qq.com for enrollment information.
Where is the NCT06782815 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06782815 clinical trial?
NCT06782815 is sponsored by Chuanlong Zhou. The trial plans to enroll 96 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.